DSMB reviews phase Ib part of ILIAD study of ilixadencel with pembrolizumab in advanced cancers July 26, 2021 No Comments
Innovent initiates phase Ia study of anti-PD-1/TIGIT bispecific antibody IBI-321 July 26, 2021 No Comments
China's NMPA clears initiation of clinical trials with ESG-401 for solid tumors July 23, 2021 No Comments
Antengene obtains HREC approval in Australia for phase I study of ATG-101 in solid tumors and NHL July 22, 2021 No Comments
RSS